FOX chase cancer center:1106812 [17-000974]
Ended Purchase Order Awarded Last action
- Contract number
- HHSN302201700027P
- Awardee
-
Fox Chase Cancer Center UEI YAFTWL7ZCBN8
- Awarding agency
-
National Human Genome Research Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,840
Award facts
- Contract value 100% obligated
- $3,840.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$38 | |
| Original award | $3,878 |
About this award
The National Human Genome Research Institute issued a purchase order to Fox Chase Cancer Center on December 2, 2016, for sequencing services valued at $3,840.00. Place of performance is Bethesda, Maryland. The order carries a firm fixed price structure and is scheduled for completion by December 31, 2016.
Quick answers
Who was awarded contract HHSN302201700027P?
HHSN302201700027P was awarded to Fox Chase Cancer Center by National Human Genome Research Institute (National Institutes of Health) on December 2, 2016.
How much is contract HHSN302201700027P worth?
The government has obligated $3,840 on HHSN302201700027P.
Was contract HHSN302201700027P competed?
The extent of competition for HHSN302201700027P was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award